報價延遲最少15分鐘:2026/06/03 07:42 EDT
盤前時段
|
||||
|
-- 
|
|
|
常規時段 (已結束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.06
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-3.59/-0.42
|
|
企業價值
57.87M
|
| 資產負債 |
|
每股賬面淨值
-1.31
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
26.55M
|
|
每股收益
0.52
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment. |
